Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: J Urol. 2018 May 7;200(4):856–861. doi: 10.1016/j.juro.2018.05.007

Table 1.

Demographic and clinical information comparing women with OAB and those with OAB undergoing 3rd line OAB therapy. Data presented a mean (95% confidence interval) or number (%).

OAB 3rd Line OAB P Value
Number of women 55 39
Age 47.0 (43.2 - 50.8) 56.3 (51.4 - 61.3) 0.0029
Race/ethnicity
Non-Hispanic White 44 (80.0) 29 (74.4) 0.615
Non-Hispanic Black 9 (16.4) 10 (25.6)
Asian 1 (1.8) 0
Hispanic 1 (1.8) 0
Education
9th to 11th grade 0 2 (5.1) 0.002
High school 2 (3.6) 11 (28.2)
Some college 17 (30.9) 12 (30.8)
College Graduate 25 (45.5) 9 (23.1)
Graduate or professional 11 (20.) 5 (12.8)
General Health
Excellent 4 (7.3) 4 (10.3) 0.018
Very good 30 (54.6) 11 (28.2)
Good 17 (30.9) 13 (33.3)
Fair 3 (5.5) 10 (25.6)
Poor 1 (1.8) 1 (2.6)
Prior Pelvic Surgery
Incontinence Surgery 2 (3.6) 13 (33.3) <.001
Hysterectomy 15 (27.3) 21 (53.9) 0.011
Prolapse Surgery 3 (5.5) 6 (15.4) 0.156
Current OAB medication 5 (9) 20 (51) <.001
Anticholinergic medication 4 (4) 17 (44) <.001